TJPC(SH:600488) Zheng Quan Zhi Xing·2025-08-01 16:10Core Viewpoint - Tianjin Pharmaceutical Co., Ltd. is proposing to change its business scope, abolish the supervisory board, and amend its articles of association to enhance corporate governance and operational efficiency [1][3][4]. Business Scope Changes - The company plans to expand its business scope to include drug import and export, technology import and export, import and export agency, and goods import and export [1][8]. - The revised business scope will include the following licensed projects: drug production, entrusted drug production, veterinary drug production, cosmetics production, food additive production, feed additive production, hazardous chemicals operation, special equipment design, and drug import and export [1][8]. Articles of Association Amendments - The amendments to the articles of association aim to align with the Company Law and other relevant regulations, ensuring the protection of the rights of the company, shareholders, and creditors [3][4]. - Key changes include the removal of the supervisory board, with the audit and risk control committee of the board of directors assuming the supervisory functions [1][3]. - The articles will also clarify the responsibilities and rights of shareholders, including the ability to sue the company or its directors for breaches of duty [7][14]. Corporate Governance Enhancements - The company emphasizes the importance of maintaining a high standard of corporate governance to protect the interests of shareholders and ensure compliance with legal requirements [1][3]. - The amendments will also address the roles and responsibilities of the general manager and other senior management, ensuring accountability and legal compliance [5][6][7].